Post-approval studies (Phase 4)Ended earlyNCT01436643
What this trial is testing
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Who this might be right for
DepressionRelapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 54